Page 1 | Search Results | Hematology, ASH Education Program

1-16 of 16

Sort by

Sort Order Select

Journal Articles

What we have learned about direct oral anticoagulant reversal

Deborah M. Siegal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 198–203.

https://doi.org/10.1182/hematology.2019000072

Published: 2019

Journal Articles

Breadth of complications of long-term oral anticoagulant care

Walter Ageno, Marco Donadini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 432–438.

https://doi.org/10.1182/asheducation-2018.1.432

Published: 2018

Journal Articles

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Vittorio Pengo, Gentian Denas

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 332–338.

https://doi.org/10.1182/asheducation-2018.1.332

Published: 2018

Journal Articles

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Sara R. Vazquez

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 339–347.

https://doi.org/10.1182/asheducation-2018.1.339

Published: 2018

Journal Articles

Monitoring target-specific oral anticoagulants

Barbara A. Konkle

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 329–333.

https://doi.org/10.1182/asheducation-2014.1.329

Published: 2014

Journal Articles

Bleeding complications of targeted oral anticoagulants: what is the risk?

Michael Levine, Joshua N. Goldstein

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 504–509.

https://doi.org/10.1182/asheducation-2014.1.504

Published: 2014

Journal Articles

The target-specific oral anticoagulants: practical considerations

David A. Garcia

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 510–513.

https://doi.org/10.1182/asheducation-2014.1.510

Published: 2014

Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.

https://doi.org/10.1182/asheducation-2014.1.518

Published: 2014

Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.

https://doi.org/10.1182/asheducation-2013.1.44

Published: 2013

Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.

https://doi.org/10.1182/asheducation-2013.1.464

Published: 2013

Journal Articles

Perioperative management of patients on chronic antithrombotic therapy

Thomas L. Ortel

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 529–535.

https://doi.org/10.1182/asheducation.V2012.1.529.3799663

Published: 2012

Journal Articles

New oral anticoagulants: which one should my patient use?

Jeffrey I. Weitz, Peter L. Gross

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 536–540.

https://doi.org/10.1182/asheducation.V2012.1.536.3798545

Published: 2012

Journal Articles

Prevention of venous thromboembolism: consensus, controversies, and challenges

Rita Selby, William Geerts

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 286–292.

https://doi.org/10.1182/asheducation-2009.1.286

Published: 2009

Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.

https://doi.org/10.1182/asheducation-2008.1.259

Published: 2008

Journal Articles

Consultations on Patients with Venous or Arterial Diseases

Barbara M. Alving, Charles W. Francis, William R. Hiatt, Mark R. Jackson

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 540–558.

https://doi.org/10.1182/asheducation-2003.1.540

Published: 2003

Journal Articles

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism

Jack E. Ansell, Jeffrey I. Weitz, Anthony J. Comerota

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 266–284.

https://doi.org/10.1182/asheducation.V2000.1.266.266

Published: 2000

NARROW

What we have learned about direct oral anticoagulant reversal

Breadth of complications of long-term oral anticoagulant care

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Monitoring target-specific oral anticoagulants

Bleeding complications of targeted oral anticoagulants: what is the risk?

The target-specific oral anticoagulants: practical considerations

Reversing targeted oral anticoagulants

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Pros and cons of new oral anticoagulants

Perioperative management of patients on chronic antithrombotic therapy

New oral anticoagulants: which one should my patient use?

Prevention of venous thromboembolism: consensus, controversies, and challenges

New Issues in Oral Anticoagulants

Consultations on Patients with Venous or Arterial Diseases

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only